| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/12/2008 | CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | CA2679410A1 Novel method and compositions |
| 09/12/2008 | CA2679395A1 Serial siphon valves for fluidic or microfluidic devices |
| 09/12/2008 | CA2679388A1 Nucleic acid compounds for inhibiting ras gene expression and uses thereof |
| 09/12/2008 | CA2679387A1 Nucleic acid compounds for inhibiting akt gene expression and uses thereof |
| 09/12/2008 | CA2679347A1 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof |
| 09/12/2008 | CA2679342A1 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof |
| 09/12/2008 | CA2679339A1 Nucleic acid compounds for inhibiting wnt gene expression and uses thereof |
| 09/12/2008 | CA2679045A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 09/12/2008 | CA2678628A1 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/12/2008 | CA2677925A1 Improvement of protein production |
| 09/12/2008 | CA2661896A1 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin |
| 09/11/2008 | US20080222756 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 09/11/2008 | US20080222755 Method for modifying plant morphology, biochemistry and physiology |
| 09/11/2008 | US20080222754 Methods of Modulating Glucosinolate Production in Plants |
| 09/11/2008 | US20080222753 Transgenic seeds, plants; recombinant expression cassettes; host cells |
| 09/11/2008 | US20080222752 Methods for Enhancing Expression of Secondary Cell Wall Cellulose Synthases in Plants |
| 09/11/2008 | US20080222751 Source-sink; cultivating transgenic plant having expression system inducible during germination, harvesting seeds, germinating in air lift tank, harnessing expression system integrated in plant genome for de novo synthesis |
| 09/11/2008 | US20080222750 Binding proteins comprising transduction domain operably linked to targeting signal peptide comprising high mobility group boxes |
| 09/11/2008 | US20080222745 Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning |
| 09/11/2008 | US20080222743 RNA interference and disease resistance in avians |
| 09/11/2008 | US20080222742 Plasmid comprising ribosmal protein promoter sequences for use as tool in controlling and enhancing genic expression in transgenic cells; biodrug |
| 09/11/2008 | US20080222740 Improved properties such as temperature and/or pH stability, pH activity profile, temperature activity profile, substrate profile, improved performance in animal feed in vitro or in vivo |
| 09/11/2008 | US20080222738 Transgenic mouse model with deficient respiratory chain function in dopamine neurons; used to develop pharmacological, gene therapy or cell therapy |
| 09/11/2008 | US20080221317 siRNA targeting cystic fibrosis transmembrane conductance regulator (CFTR) |
| 09/11/2008 | US20080221309 MN Gene and Protein |
| 09/11/2008 | US20080221308 HDAC9 polypeptides and polynucleotides and uses thereof |
| 09/11/2008 | US20080221059 Novel treatment tool for cancer: rna interference of bcas2 |
| 09/11/2008 | US20080221058 Tumor-Specific Vector for Gene Therapy |
| 09/11/2008 | US20080221055 Compositions and methods for inhibiting expression of huntingtin gene |
| 09/11/2008 | US20080221054 In vitro; transgenic cells, mammals; kits |
| 09/11/2008 | US20080221053 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2 |
| 09/11/2008 | US20080221052 Modulation of Wrn-Mediated Telomere-Initiated Cell Signaling |
| 09/11/2008 | US20080221051 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221027 Administrating a composition to artificially increase sarcospan activity in a muscle tissue of the patient; increasing the dystrophin-related complex |
| 09/11/2008 | US20080221021 Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist |
| 09/11/2008 | US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 09/11/2008 | US20080221011 CR2-FH C-reactive protein, factor H fusion protein; inhibiting complement activation of the alternative pathway |
| 09/11/2008 | US20080220987 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 09/11/2008 | US20080220981 Chimeric binding peptide library screening method |
| 09/11/2008 | US20080220971 Novel method to increase pathogen resistance in plants |
| 09/11/2008 | US20080220528 Using vector transofmation to replicate human immunodeficiency virus envelope proteins; mapping resistance determinants in viral genomes |
| 09/11/2008 | US20080220527 Modular transfection systems |
| 09/11/2008 | US20080220519 Mutated e. coli heat-labile enterotoxin |
| 09/11/2008 | US20080220518 Method From the Selection of Biomolecules From Biomolecules Variant Libraries |
| 09/11/2008 | US20080220517 Site-specific cell perforation technique |
| 09/11/2008 | US20080220503 Screening method for genes of brewing yeast |
| 09/11/2008 | US20080220502 Using vector comprising mutator genes as tool for generation of genomic variance; enhancing rate of genic change |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220498 Modified hydrolase for enhancing nutrient quality of animal feeds |
| 09/11/2008 | US20080220484 Reducing substituted alkanones such as 3-methylamino-1-(2-thienyl)-propan-1-one; biosynthesis; expression cassettes; host cells; for production of duloxetine |
| 09/11/2008 | US20080220477 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis |
| 09/11/2008 | US20080220476 Thermostable Alpha-Amylases |
| 09/11/2008 | US20080220475 mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS |
| 09/11/2008 | US20080220474 Using transgenic yeast comprising omega -3 and/or omega -6 fatty acid promoters as bioreactor for heterologous gene expression |
| 09/11/2008 | US20080220472 In Vivo Incorporation of Alkynyl Amino Acids into Proteins in Eubacteria |
| 09/11/2008 | US20080220471 Nucleotide sequences coding Tet repressor (TetR) protein for use as gene targeting tool in genetic engineering |
| 09/11/2008 | US20080220470 Protein hydrolysate rich in tripeptides |
| 09/11/2008 | US20080220460 Modified flavin adenine dinucleotide dependent glucose dehydrogenase |
| 09/11/2008 | US20080220456 Luminescence resonance energy transfer (lret) assays for clostridial toxin activity |
| 09/11/2008 | US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR |
| 09/11/2008 | US20080220451 T1r2 binding assays |
| 09/11/2008 | US20080220429 Single nucleotide polymorphisms and the identification of lactose intolerance |
| 09/11/2008 | US20080220420 Method of Detecting Gene Polymorphism, Method of Diagnosing, Apparatus Therefor, and Test Reagent Kit |
| 09/11/2008 | US20080220419 Oligonucleotide primers/probes; cytochrome p450 monooxygenase enzyme system; expression vectors; kits |
| 09/11/2008 | US20080220417 Novel Alanine Transaminase Enzymes and Methods of Use |
| 09/11/2008 | US20080220410 Method for replicating the hepatitis c virus |
| 09/11/2008 | US20080220118 Mutant hydrolase comprising enhanced heat resistant characteristics for use in liberating phosphorous from inorganic phosphate, phytate and/or phytic acid; improving nutrient quality of animal feeds |
| 09/11/2008 | US20080220072 Biologic modulations with nanoparticles |
| 09/11/2008 | US20080220027 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 09/11/2008 | US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering |
| 09/11/2008 | US20080220014 Recombinant viral-based malaria vaccines |
| 09/11/2008 | US20080220011 Flagellin/tumor antigen fusion for use in induction of immune response to cancer antigen; tissue targeted therapy; antitumor agents |
| 09/11/2008 | US20080220009 Composition comprising hepadnavirus core antigen for use in preparing vaccines against hepatitis infection |
| 09/11/2008 | US20080220008 Mutated Hiv Nef For Modulating Immunity |
| 09/11/2008 | US20080220007 Ehrlichia canis genes and vaccines |
| 09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
| 09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
| 09/11/2008 | US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity |
| 09/11/2008 | US20080219997 Her-2 binding antagonists |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219992 Pancreatic protein for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219981 Solid cancer antigenic polypeptide for use in designing and identifying modulators for prevention and treatment of tumorous masses |
| 09/11/2008 | US20080219971 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
| 09/11/2008 | US20080219970 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
| 09/11/2008 | US20080219968 Son of sevenless homolog 1 (SOS1) suppressive agent for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219965 Phytase Variants |
| 09/11/2008 | US20080219960 Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria |
| 09/11/2008 | US20080219959 Support Having Nanostructured Titanium Dioxide Film And Uses Thereof |
| 09/11/2008 | US20080219956 Hla homozygous cells and methods of use thereof |
| 09/11/2008 | US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |